发明申请
US20150210734A1 3-SUBSTITUTED ESTRA-1,3,5(10),16-TETRAENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS
有权
3-取代的ESTRA-1,3,5（10），16-四烯衍生物，其生产方法，含有它们的药物制剂及其用于生产药物的用途
- 专利标题： 3-SUBSTITUTED ESTRA-1,3,5(10),16-TETRAENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS
- 专利标题（中）： 3-取代的ESTRA-1,3,5（10），16-四烯衍生物，其生产方法，含有它们的药物制剂及其用于生产药物的用途
-
申请号： US14414386申请日： 2013-07-05
-
公开(公告)号： US20150210734A1公开(公告)日： 2015-07-30
- 发明人: Ulrich Bothe , Matthias Busemann , Oliver Martin Fischer , Naomi Barak , Andrea Rotgeri , Tobias Marquardt , Christian Stegmann
- 申请人： BAYER PHARMA AKTIENGESELLSCHAFT
- 优先权： DE102012211970.1 20120710
- 国际申请： PCT/EP2013/064257 WO 20130705
- 主分类号： C07J43/00
- IPC分类号： C07J43/00 ; A61K31/58
摘要：
The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.
公开/授权文献
信息查询
